nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine—CYP3A4—bone cancer	0.308	1	CbGaD
Quinidine—ABCB11—Doxorubicin—bone cancer	0.0603	0.119	CbGbCtD
Quinidine—SLC22A2—Cisplatin—bone cancer	0.058	0.115	CbGbCtD
Quinidine—ABCC2—Carboplatin—bone cancer	0.0554	0.11	CbGbCtD
Quinidine—ABCC2—Cisplatin—bone cancer	0.0473	0.0936	CbGbCtD
Quinidine—SLCO1A2—Methotrexate—bone cancer	0.0371	0.0733	CbGbCtD
Quinidine—SLCO1B1—Methotrexate—bone cancer	0.035	0.0692	CbGbCtD
Quinidine—SLC22A8—Methotrexate—bone cancer	0.0323	0.0638	CbGbCtD
Quinidine—ABCC2—Doxorubicin—bone cancer	0.0317	0.0627	CbGbCtD
Quinidine—ABCC2—Methotrexate—bone cancer	0.0307	0.0608	CbGbCtD
Quinidine—CYP2B6—Cisplatin—bone cancer	0.0301	0.0595	CbGbCtD
Quinidine—CYP2B6—Doxorubicin—bone cancer	0.0202	0.0399	CbGbCtD
Quinidine—CYP2C9—Cisplatin—bone cancer	0.0159	0.0314	CbGbCtD
Quinidine—ABCB1—Cisplatin—bone cancer	0.0154	0.0305	CbGbCtD
Quinidine—ABCB1—Doxorubicin—bone cancer	0.0103	0.0204	CbGbCtD
Quinidine—ABCB1—Methotrexate—bone cancer	0.01	0.0198	CbGbCtD
Quinidine—CYP2D6—Doxorubicin—bone cancer	0.00974	0.0193	CbGbCtD
Quinidine—CYP3A4—Doxorubicin—bone cancer	0.00619	0.0123	CbGbCtD
Quinidine—Quinine—CYP3A4—bone cancer	0.00102	1	CrCbGaD
Quinidine—Leukopenia—Cisplatin—bone cancer	0.000331	0.00309	CcSEcCtD
Quinidine—Dermatitis bullous—Epirubicin—bone cancer	0.00033	0.00308	CcSEcCtD
Quinidine—Purpura—Epirubicin—bone cancer	0.000328	0.00306	CcSEcCtD
Quinidine—Eczema—Doxorubicin—bone cancer	0.000325	0.00303	CcSEcCtD
Quinidine—Hypoglycaemia—Epirubicin—bone cancer	0.000324	0.00302	CcSEcCtD
Quinidine—Convulsion—Cisplatin—bone cancer	0.000321	0.00299	CcSEcCtD
Quinidine—Ataxia—Methotrexate—bone cancer	0.000317	0.00296	CcSEcCtD
Quinidine—Renal failure acute—Doxorubicin—bone cancer	0.000316	0.00295	CcSEcCtD
Quinidine—Diplopia—Epirubicin—bone cancer	0.000316	0.00295	CcSEcCtD
Quinidine—Myalgia—Cisplatin—bone cancer	0.000315	0.00294	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000313	0.00292	CcSEcCtD
Quinidine—Liver function test abnormal—Methotrexate—bone cancer	0.000311	0.00291	CcSEcCtD
Quinidine—Dermatitis exfoliative—Doxorubicin—bone cancer	0.00031	0.00289	CcSEcCtD
Quinidine—Renal impairment—Doxorubicin—bone cancer	0.000307	0.00286	CcSEcCtD
Quinidine—Dermatitis bullous—Doxorubicin—bone cancer	0.000306	0.00285	CcSEcCtD
Quinidine—Breast disorder—Methotrexate—bone cancer	0.000305	0.00284	CcSEcCtD
Quinidine—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.000304	0.00284	CcSEcCtD
Quinidine—Purpura—Doxorubicin—bone cancer	0.000303	0.00283	CcSEcCtD
Quinidine—Oedema—Cisplatin—bone cancer	0.000302	0.00282	CcSEcCtD
Quinidine—Cardiac arrest—Epirubicin—bone cancer	0.0003	0.0028	CcSEcCtD
Quinidine—Hypoglycaemia—Doxorubicin—bone cancer	0.000299	0.00279	CcSEcCtD
Quinidine—Ataxia—Epirubicin—bone cancer	0.000297	0.00277	CcSEcCtD
Quinidine—Nervous system disorder—Cisplatin—bone cancer	0.000296	0.00277	CcSEcCtD
Quinidine—Thrombocytopenia—Cisplatin—bone cancer	0.000296	0.00276	CcSEcCtD
Quinidine—Tachycardia—Cisplatin—bone cancer	0.000295	0.00275	CcSEcCtD
Quinidine—Skin disorder—Cisplatin—bone cancer	0.000294	0.00274	CcSEcCtD
Quinidine—Diplopia—Doxorubicin—bone cancer	0.000292	0.00273	CcSEcCtD
Quinidine—Hyperhidrosis—Cisplatin—bone cancer	0.000292	0.00273	CcSEcCtD
Quinidine—Asthma—Methotrexate—bone cancer	0.000292	0.00272	CcSEcCtD
Quinidine—Liver function test abnormal—Epirubicin—bone cancer	0.000292	0.00272	CcSEcCtD
Quinidine—Abdominal pain upper—Epirubicin—bone cancer	0.000288	0.00269	CcSEcCtD
Quinidine—Orthostatic hypotension—Epirubicin—bone cancer	0.000288	0.00269	CcSEcCtD
Quinidine—Anorexia—Cisplatin—bone cancer	0.000288	0.00269	CcSEcCtD
Quinidine—Breast disorder—Epirubicin—bone cancer	0.000285	0.00266	CcSEcCtD
Quinidine—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.000284	0.00265	CcSEcCtD
Quinidine—Hypotension—Cisplatin—bone cancer	0.000282	0.00263	CcSEcCtD
Quinidine—Muscular weakness—Epirubicin—bone cancer	0.000278	0.0026	CcSEcCtD
Quinidine—Cardiac arrest—Doxorubicin—bone cancer	0.000278	0.00259	CcSEcCtD
Quinidine—Pancytopenia—Methotrexate—bone cancer	0.000277	0.00258	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000275	0.00257	CcSEcCtD
Quinidine—Ataxia—Doxorubicin—bone cancer	0.000275	0.00256	CcSEcCtD
Quinidine—Asthma—Epirubicin—bone cancer	0.000273	0.00255	CcSEcCtD
Quinidine—Neutropenia—Methotrexate—bone cancer	0.000273	0.00254	CcSEcCtD
Quinidine—Liver function test abnormal—Doxorubicin—bone cancer	0.00027	0.00252	CcSEcCtD
Quinidine—Dyspnoea—Cisplatin—bone cancer	0.000269	0.00251	CcSEcCtD
Quinidine—Abdominal pain upper—Doxorubicin—bone cancer	0.000267	0.00249	CcSEcCtD
Quinidine—Orthostatic hypotension—Doxorubicin—bone cancer	0.000267	0.00249	CcSEcCtD
Quinidine—Photosensitivity reaction—Methotrexate—bone cancer	0.000266	0.00248	CcSEcCtD
Quinidine—Angina pectoris—Epirubicin—bone cancer	0.000266	0.00248	CcSEcCtD
Quinidine—Breast disorder—Doxorubicin—bone cancer	0.000264	0.00246	CcSEcCtD
Quinidine—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.000263	0.00245	CcSEcCtD
Quinidine—Decreased appetite—Cisplatin—bone cancer	0.000263	0.00245	CcSEcCtD
Quinidine—Gastrointestinal disorder—Cisplatin—bone cancer	0.000261	0.00243	CcSEcCtD
Quinidine—Pancytopenia—Epirubicin—bone cancer	0.000259	0.00242	CcSEcCtD
Quinidine—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000258	0.00241	CcSEcCtD
Quinidine—Muscular weakness—Doxorubicin—bone cancer	0.000258	0.0024	CcSEcCtD
Quinidine—Renal failure—Methotrexate—bone cancer	0.000256	0.00238	CcSEcCtD
Quinidine—Neutropenia—Epirubicin—bone cancer	0.000255	0.00238	CcSEcCtD
Quinidine—Asthma—Doxorubicin—bone cancer	0.000252	0.00236	CcSEcCtD
Quinidine—Sweating—Methotrexate—bone cancer	0.000249	0.00233	CcSEcCtD
Quinidine—Photosensitivity reaction—Epirubicin—bone cancer	0.000249	0.00232	CcSEcCtD
Quinidine—Feeling abnormal—Cisplatin—bone cancer	0.000249	0.00232	CcSEcCtD
Quinidine—Angina pectoris—Doxorubicin—bone cancer	0.000246	0.0023	CcSEcCtD
Quinidine—Agranulocytosis—Methotrexate—bone cancer	0.000243	0.00226	CcSEcCtD
Quinidine—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000241	0.00225	CcSEcCtD
Quinidine—Pancytopenia—Doxorubicin—bone cancer	0.00024	0.00224	CcSEcCtD
Quinidine—Renal failure—Epirubicin—bone cancer	0.000239	0.00223	CcSEcCtD
Quinidine—Body temperature increased—Cisplatin—bone cancer	0.000239	0.00223	CcSEcCtD
Quinidine—Jaundice—Epirubicin—bone cancer	0.000237	0.00221	CcSEcCtD
Quinidine—Neutropenia—Doxorubicin—bone cancer	0.000236	0.0022	CcSEcCtD
Quinidine—Haemoglobin—Methotrexate—bone cancer	0.000235	0.00219	CcSEcCtD
Quinidine—Haemorrhage—Methotrexate—bone cancer	0.000233	0.00218	CcSEcCtD
Quinidine—Hepatitis—Methotrexate—bone cancer	0.000233	0.00218	CcSEcCtD
Quinidine—Sweating—Epirubicin—bone cancer	0.000233	0.00218	CcSEcCtD
Quinidine—Urinary tract disorder—Methotrexate—bone cancer	0.000231	0.00215	CcSEcCtD
Quinidine—Photosensitivity reaction—Doxorubicin—bone cancer	0.00023	0.00215	CcSEcCtD
Quinidine—Urethral disorder—Methotrexate—bone cancer	0.000229	0.00213	CcSEcCtD
Quinidine—Agranulocytosis—Epirubicin—bone cancer	0.000227	0.00212	CcSEcCtD
Quinidine—Visual impairment—Methotrexate—bone cancer	0.000225	0.0021	CcSEcCtD
Quinidine—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000223	0.00208	CcSEcCtD
Quinidine—Hypersensitivity—Cisplatin—bone cancer	0.000223	0.00208	CcSEcCtD
Quinidine—Bradycardia—Epirubicin—bone cancer	0.000222	0.00207	CcSEcCtD
Quinidine—Renal failure—Doxorubicin—bone cancer	0.000221	0.00207	CcSEcCtD
Quinidine—Erythema multiforme—Methotrexate—bone cancer	0.000221	0.00206	CcSEcCtD
Quinidine—Haemoglobin—Epirubicin—bone cancer	0.00022	0.00205	CcSEcCtD
Quinidine—Jaundice—Doxorubicin—bone cancer	0.000219	0.00205	CcSEcCtD
Quinidine—Haemorrhage—Epirubicin—bone cancer	0.000218	0.00204	CcSEcCtD
Quinidine—Hepatitis—Epirubicin—bone cancer	0.000218	0.00204	CcSEcCtD
Quinidine—Eye disorder—Methotrexate—bone cancer	0.000218	0.00204	CcSEcCtD
Quinidine—Tinnitus—Methotrexate—bone cancer	0.000218	0.00203	CcSEcCtD
Quinidine—Asthenia—Cisplatin—bone cancer	0.000217	0.00202	CcSEcCtD
Quinidine—Cardiac disorder—Methotrexate—bone cancer	0.000217	0.00202	CcSEcCtD
Quinidine—Sweating—Doxorubicin—bone cancer	0.000216	0.00201	CcSEcCtD
Quinidine—Urinary tract disorder—Epirubicin—bone cancer	0.000216	0.00201	CcSEcCtD
Quinidine—Urethral disorder—Epirubicin—bone cancer	0.000214	0.002	CcSEcCtD
Quinidine—Immune system disorder—Methotrexate—bone cancer	0.000211	0.00197	CcSEcCtD
Quinidine—Visual impairment—Epirubicin—bone cancer	0.00021	0.00196	CcSEcCtD
Quinidine—Mediastinal disorder—Methotrexate—bone cancer	0.00021	0.00196	CcSEcCtD
Quinidine—Agranulocytosis—Doxorubicin—bone cancer	0.00021	0.00196	CcSEcCtD
Quinidine—Chills—Methotrexate—bone cancer	0.000209	0.00195	CcSEcCtD
Quinidine—Diarrhoea—Cisplatin—bone cancer	0.000207	0.00193	CcSEcCtD
Quinidine—Erythema multiforme—Epirubicin—bone cancer	0.000207	0.00193	CcSEcCtD
Quinidine—Bradycardia—Doxorubicin—bone cancer	0.000206	0.00192	CcSEcCtD
Quinidine—Mental disorder—Methotrexate—bone cancer	0.000204	0.00191	CcSEcCtD
Quinidine—Eye disorder—Epirubicin—bone cancer	0.000204	0.0019	CcSEcCtD
Quinidine—Tinnitus—Epirubicin—bone cancer	0.000204	0.0019	CcSEcCtD
Quinidine—Malnutrition—Methotrexate—bone cancer	0.000203	0.0019	CcSEcCtD
Quinidine—Erythema—Methotrexate—bone cancer	0.000203	0.0019	CcSEcCtD
Quinidine—Haemoglobin—Doxorubicin—bone cancer	0.000203	0.0019	CcSEcCtD
Quinidine—Cardiac disorder—Epirubicin—bone cancer	0.000203	0.00189	CcSEcCtD
Quinidine—Flushing—Epirubicin—bone cancer	0.000203	0.00189	CcSEcCtD
Quinidine—Hepatitis—Doxorubicin—bone cancer	0.000202	0.00189	CcSEcCtD
Quinidine—Haemorrhage—Doxorubicin—bone cancer	0.000202	0.00189	CcSEcCtD
Quinidine—Urinary tract disorder—Doxorubicin—bone cancer	0.0002	0.00186	CcSEcCtD
Quinidine—Urethral disorder—Doxorubicin—bone cancer	0.000198	0.00185	CcSEcCtD
Quinidine—Immune system disorder—Epirubicin—bone cancer	0.000197	0.00184	CcSEcCtD
Quinidine—Mediastinal disorder—Epirubicin—bone cancer	0.000197	0.00184	CcSEcCtD
Quinidine—Chills—Epirubicin—bone cancer	0.000196	0.00183	CcSEcCtD
Quinidine—Visual impairment—Doxorubicin—bone cancer	0.000195	0.00182	CcSEcCtD
Quinidine—Vomiting—Cisplatin—bone cancer	0.000192	0.00179	CcSEcCtD
Quinidine—Vision blurred—Methotrexate—bone cancer	0.000191	0.00179	CcSEcCtD
Quinidine—Mental disorder—Epirubicin—bone cancer	0.000191	0.00179	CcSEcCtD
Quinidine—Erythema multiforme—Doxorubicin—bone cancer	0.000191	0.00178	CcSEcCtD
Quinidine—Rash—Cisplatin—bone cancer	0.000191	0.00178	CcSEcCtD
Quinidine—Dermatitis—Cisplatin—bone cancer	0.00019	0.00178	CcSEcCtD
Quinidine—Malnutrition—Epirubicin—bone cancer	0.00019	0.00177	CcSEcCtD
Quinidine—Erythema—Epirubicin—bone cancer	0.00019	0.00177	CcSEcCtD
Quinidine—Eye disorder—Doxorubicin—bone cancer	0.000189	0.00176	CcSEcCtD
Quinidine—Tinnitus—Doxorubicin—bone cancer	0.000188	0.00176	CcSEcCtD
Quinidine—Flushing—Doxorubicin—bone cancer	0.000188	0.00175	CcSEcCtD
Quinidine—Cardiac disorder—Doxorubicin—bone cancer	0.000188	0.00175	CcSEcCtD
Quinidine—Immune system disorder—Doxorubicin—bone cancer	0.000183	0.0017	CcSEcCtD
Quinidine—Vertigo—Methotrexate—bone cancer	0.000183	0.0017	CcSEcCtD
Quinidine—Mediastinal disorder—Doxorubicin—bone cancer	0.000182	0.0017	CcSEcCtD
Quinidine—Leukopenia—Methotrexate—bone cancer	0.000182	0.0017	CcSEcCtD
Quinidine—Chills—Doxorubicin—bone cancer	0.000181	0.00169	CcSEcCtD
Quinidine—Nausea—Cisplatin—bone cancer	0.000179	0.00167	CcSEcCtD
Quinidine—Vision blurred—Epirubicin—bone cancer	0.000179	0.00167	CcSEcCtD
Quinidine—Mental disorder—Doxorubicin—bone cancer	0.000177	0.00165	CcSEcCtD
Quinidine—Convulsion—Methotrexate—bone cancer	0.000176	0.00164	CcSEcCtD
Quinidine—Erythema—Doxorubicin—bone cancer	0.000176	0.00164	CcSEcCtD
Quinidine—Malnutrition—Doxorubicin—bone cancer	0.000176	0.00164	CcSEcCtD
Quinidine—Agitation—Epirubicin—bone cancer	0.000175	0.00163	CcSEcCtD
Quinidine—Chest pain—Methotrexate—bone cancer	0.000173	0.00161	CcSEcCtD
Quinidine—Myalgia—Methotrexate—bone cancer	0.000173	0.00161	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000172	0.0016	CcSEcCtD
Quinidine—Vertigo—Epirubicin—bone cancer	0.000171	0.00159	CcSEcCtD
Quinidine—Syncope—Epirubicin—bone cancer	0.000171	0.00159	CcSEcCtD
Quinidine—Leukopenia—Epirubicin—bone cancer	0.00017	0.00159	CcSEcCtD
Quinidine—Palpitations—Epirubicin—bone cancer	0.000168	0.00157	CcSEcCtD
Quinidine—Confusional state—Methotrexate—bone cancer	0.000167	0.00156	CcSEcCtD
Quinidine—Loss of consciousness—Epirubicin—bone cancer	0.000167	0.00156	CcSEcCtD
Quinidine—Vision blurred—Doxorubicin—bone cancer	0.000166	0.00155	CcSEcCtD
Quinidine—Convulsion—Epirubicin—bone cancer	0.000165	0.00154	CcSEcCtD
Quinidine—Nervous system disorder—Methotrexate—bone cancer	0.000163	0.00152	CcSEcCtD
Quinidine—Thrombocytopenia—Methotrexate—bone cancer	0.000162	0.00152	CcSEcCtD
Quinidine—Chest pain—Epirubicin—bone cancer	0.000162	0.00151	CcSEcCtD
Quinidine—Myalgia—Epirubicin—bone cancer	0.000162	0.00151	CcSEcCtD
Quinidine—Agitation—Doxorubicin—bone cancer	0.000162	0.00151	CcSEcCtD
Quinidine—Skin disorder—Methotrexate—bone cancer	0.000161	0.0015	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000161	0.0015	CcSEcCtD
Quinidine—Hyperhidrosis—Methotrexate—bone cancer	0.00016	0.0015	CcSEcCtD
Quinidine—Vertigo—Doxorubicin—bone cancer	0.000158	0.00147	CcSEcCtD
Quinidine—Anorexia—Methotrexate—bone cancer	0.000158	0.00147	CcSEcCtD
Quinidine—Syncope—Doxorubicin—bone cancer	0.000158	0.00147	CcSEcCtD
Quinidine—Leukopenia—Doxorubicin—bone cancer	0.000157	0.00147	CcSEcCtD
Quinidine—Confusional state—Epirubicin—bone cancer	0.000156	0.00146	CcSEcCtD
Quinidine—Palpitations—Doxorubicin—bone cancer	0.000155	0.00145	CcSEcCtD
Quinidine—Oedema—Epirubicin—bone cancer	0.000155	0.00145	CcSEcCtD
Quinidine—Hypotension—Methotrexate—bone cancer	0.000155	0.00145	CcSEcCtD
Quinidine—Loss of consciousness—Doxorubicin—bone cancer	0.000155	0.00144	CcSEcCtD
Quinidine—Shock—Epirubicin—bone cancer	0.000153	0.00142	CcSEcCtD
Quinidine—Convulsion—Doxorubicin—bone cancer	0.000152	0.00142	CcSEcCtD
Quinidine—Nervous system disorder—Epirubicin—bone cancer	0.000152	0.00142	CcSEcCtD
Quinidine—Thrombocytopenia—Epirubicin—bone cancer	0.000152	0.00142	CcSEcCtD
Quinidine—Tachycardia—Epirubicin—bone cancer	0.000151	0.00141	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000151	0.00141	CcSEcCtD
Quinidine—Skin disorder—Epirubicin—bone cancer	0.000151	0.00141	CcSEcCtD
Quinidine—Hyperhidrosis—Epirubicin—bone cancer	0.00015	0.0014	CcSEcCtD
Quinidine—Chest pain—Doxorubicin—bone cancer	0.00015	0.0014	CcSEcCtD
Quinidine—Myalgia—Doxorubicin—bone cancer	0.00015	0.0014	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000149	0.00139	CcSEcCtD
Quinidine—Anorexia—Epirubicin—bone cancer	0.000148	0.00138	CcSEcCtD
Quinidine—Dyspnoea—Methotrexate—bone cancer	0.000148	0.00138	CcSEcCtD
Quinidine—Hypotension—Epirubicin—bone cancer	0.000145	0.00135	CcSEcCtD
Quinidine—Confusional state—Doxorubicin—bone cancer	0.000145	0.00135	CcSEcCtD
Quinidine—Decreased appetite—Methotrexate—bone cancer	0.000144	0.00135	CcSEcCtD
Quinidine—Oedema—Doxorubicin—bone cancer	0.000144	0.00134	CcSEcCtD
Quinidine—Gastrointestinal disorder—Methotrexate—bone cancer	0.000143	0.00134	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000141	0.00132	CcSEcCtD
Quinidine—Shock—Doxorubicin—bone cancer	0.000141	0.00132	CcSEcCtD
Quinidine—Nervous system disorder—Doxorubicin—bone cancer	0.000141	0.00131	CcSEcCtD
Quinidine—Thrombocytopenia—Doxorubicin—bone cancer	0.000141	0.00131	CcSEcCtD
Quinidine—Tachycardia—Doxorubicin—bone cancer	0.00014	0.00131	CcSEcCtD
Quinidine—Skin disorder—Doxorubicin—bone cancer	0.000139	0.0013	CcSEcCtD
Quinidine—Hyperhidrosis—Doxorubicin—bone cancer	0.000139	0.0013	CcSEcCtD
Quinidine—Dyspnoea—Epirubicin—bone cancer	0.000138	0.00129	CcSEcCtD
Quinidine—Anorexia—Doxorubicin—bone cancer	0.000137	0.00128	CcSEcCtD
Quinidine—Feeling abnormal—Methotrexate—bone cancer	0.000137	0.00128	CcSEcCtD
Quinidine—Gastrointestinal pain—Methotrexate—bone cancer	0.000136	0.00127	CcSEcCtD
Quinidine—Decreased appetite—Epirubicin—bone cancer	0.000135	0.00126	CcSEcCtD
Quinidine—Hypotension—Doxorubicin—bone cancer	0.000134	0.00125	CcSEcCtD
Quinidine—Gastrointestinal disorder—Epirubicin—bone cancer	0.000134	0.00125	CcSEcCtD
Quinidine—Urticaria—Methotrexate—bone cancer	0.000132	0.00123	CcSEcCtD
Quinidine—Body temperature increased—Methotrexate—bone cancer	0.000131	0.00122	CcSEcCtD
Quinidine—Abdominal pain—Methotrexate—bone cancer	0.000131	0.00122	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000131	0.00122	CcSEcCtD
Quinidine—Dyspnoea—Doxorubicin—bone cancer	0.000128	0.00119	CcSEcCtD
Quinidine—Feeling abnormal—Epirubicin—bone cancer	0.000128	0.00119	CcSEcCtD
Quinidine—Gastrointestinal pain—Epirubicin—bone cancer	0.000127	0.00118	CcSEcCtD
Quinidine—Decreased appetite—Doxorubicin—bone cancer	0.000125	0.00116	CcSEcCtD
Quinidine—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000124	0.00116	CcSEcCtD
Quinidine—Urticaria—Epirubicin—bone cancer	0.000123	0.00115	CcSEcCtD
Quinidine—Abdominal pain—Epirubicin—bone cancer	0.000123	0.00114	CcSEcCtD
Quinidine—Body temperature increased—Epirubicin—bone cancer	0.000123	0.00114	CcSEcCtD
Quinidine—Hypersensitivity—Methotrexate—bone cancer	0.000122	0.00114	CcSEcCtD
Quinidine—Asthenia—Methotrexate—bone cancer	0.000119	0.00111	CcSEcCtD
Quinidine—Feeling abnormal—Doxorubicin—bone cancer	0.000118	0.0011	CcSEcCtD
Quinidine—Gastrointestinal pain—Doxorubicin—bone cancer	0.000117	0.0011	CcSEcCtD
Quinidine—Pruritus—Methotrexate—bone cancer	0.000117	0.00109	CcSEcCtD
Quinidine—Hypersensitivity—Epirubicin—bone cancer	0.000114	0.00107	CcSEcCtD
Quinidine—Urticaria—Doxorubicin—bone cancer	0.000114	0.00106	CcSEcCtD
Quinidine—Body temperature increased—Doxorubicin—bone cancer	0.000114	0.00106	CcSEcCtD
Quinidine—Abdominal pain—Doxorubicin—bone cancer	0.000114	0.00106	CcSEcCtD
Quinidine—Diarrhoea—Methotrexate—bone cancer	0.000113	0.00106	CcSEcCtD
Quinidine—Asthenia—Epirubicin—bone cancer	0.000111	0.00104	CcSEcCtD
Quinidine—Pruritus—Epirubicin—bone cancer	0.00011	0.00102	CcSEcCtD
Quinidine—Dizziness—Methotrexate—bone cancer	0.00011	0.00102	CcSEcCtD
Quinidine—Diarrhoea—Epirubicin—bone cancer	0.000106	0.000991	CcSEcCtD
Quinidine—Hypersensitivity—Doxorubicin—bone cancer	0.000106	0.000987	CcSEcCtD
Quinidine—Vomiting—Methotrexate—bone cancer	0.000105	0.000984	CcSEcCtD
Quinidine—Rash—Methotrexate—bone cancer	0.000105	0.000976	CcSEcCtD
Quinidine—Dermatitis—Methotrexate—bone cancer	0.000104	0.000975	CcSEcCtD
Quinidine—Headache—Methotrexate—bone cancer	0.000104	0.000969	CcSEcCtD
Quinidine—Asthenia—Doxorubicin—bone cancer	0.000103	0.000961	CcSEcCtD
Quinidine—Dizziness—Epirubicin—bone cancer	0.000103	0.000958	CcSEcCtD
Quinidine—Pruritus—Doxorubicin—bone cancer	0.000102	0.000948	CcSEcCtD
Quinidine—Vomiting—Epirubicin—bone cancer	9.87e-05	0.000921	CcSEcCtD
Quinidine—Nausea—Methotrexate—bone cancer	9.85e-05	0.000919	CcSEcCtD
Quinidine—Diarrhoea—Doxorubicin—bone cancer	9.82e-05	0.000917	CcSEcCtD
Quinidine—Rash—Epirubicin—bone cancer	9.78e-05	0.000913	CcSEcCtD
Quinidine—Dermatitis—Epirubicin—bone cancer	9.78e-05	0.000912	CcSEcCtD
Quinidine—Headache—Epirubicin—bone cancer	9.72e-05	0.000907	CcSEcCtD
Quinidine—Dizziness—Doxorubicin—bone cancer	9.5e-05	0.000886	CcSEcCtD
Quinidine—Nausea—Epirubicin—bone cancer	9.22e-05	0.00086	CcSEcCtD
Quinidine—Vomiting—Doxorubicin—bone cancer	9.13e-05	0.000852	CcSEcCtD
Quinidine—Rash—Doxorubicin—bone cancer	9.05e-05	0.000845	CcSEcCtD
Quinidine—Dermatitis—Doxorubicin—bone cancer	9.05e-05	0.000844	CcSEcCtD
Quinidine—Headache—Doxorubicin—bone cancer	9e-05	0.000839	CcSEcCtD
Quinidine—Nausea—Doxorubicin—bone cancer	8.53e-05	0.000796	CcSEcCtD
Quinidine—CHRM2—GPCR ligand binding—GRM1—bone cancer	7.59e-05	0.000974	CbGpPWpGaD
Quinidine—CYP1A1—Biological oxidations—CYP3A4—bone cancer	7.54e-05	0.000968	CbGpPWpGaD
Quinidine—SCN3A—Developmental Biology—CDK4—bone cancer	7.46e-05	0.000957	CbGpPWpGaD
Quinidine—SCN3A—Developmental Biology—MET—bone cancer	7.46e-05	0.000957	CbGpPWpGaD
Quinidine—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	7.44e-05	0.000955	CbGpPWpGaD
Quinidine—CYP1A1—Metapathway biotransformation—CYP3A4—bone cancer	7.44e-05	0.000954	CbGpPWpGaD
Quinidine—SLC22A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	7.29e-05	0.000936	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—NDUFA12—bone cancer	7.21e-05	0.000925	CbGpPWpGaD
Quinidine—SCN2A—Developmental Biology—MET—bone cancer	7.16e-05	0.00092	CbGpPWpGaD
Quinidine—SCN2A—Developmental Biology—CDK4—bone cancer	7.16e-05	0.00092	CbGpPWpGaD
Quinidine—CYP1A2—Phase II conjugation—GSTP1—bone cancer	7.03e-05	0.000902	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—NT5C3A—bone cancer	6.99e-05	0.000897	CbGpPWpGaD
Quinidine—CYP2B6—Biological oxidations—GSTP1—bone cancer	6.98e-05	0.000896	CbGpPWpGaD
Quinidine—CYP2C8—Biological oxidations—CYP3A4—bone cancer	6.91e-05	0.000887	CbGpPWpGaD
Quinidine—SCN1A—Developmental Biology—CDK4—bone cancer	6.91e-05	0.000887	CbGpPWpGaD
Quinidine—SCN1A—Developmental Biology—MET—bone cancer	6.91e-05	0.000887	CbGpPWpGaD
Quinidine—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	6.89e-05	0.000884	CbGpPWpGaD
Quinidine—CYP2E1—Biological oxidations—GSTP1—bone cancer	6.84e-05	0.000878	CbGpPWpGaD
Quinidine—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	6.82e-05	0.000875	CbGpPWpGaD
Quinidine—SCN5A—Axon guidance—MET—bone cancer	6.81e-05	0.000874	CbGpPWpGaD
Quinidine—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—bone cancer	6.8e-05	0.000873	CbGpPWpGaD
Quinidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	6.8e-05	0.000873	CbGpPWpGaD
Quinidine—SLC22A1—Transmembrane transport of small molecules—TUBB2A—bone cancer	6.8e-05	0.000873	CbGpPWpGaD
Quinidine—CYP2E1—Metapathway biotransformation—GSTP1—bone cancer	6.75e-05	0.000866	CbGpPWpGaD
Quinidine—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	6.7e-05	0.00086	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	6.68e-05	0.000857	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—NDUFA12—bone cancer	6.62e-05	0.000849	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—NDUFA12—bone cancer	6.61e-05	0.000848	CbGpPWpGaD
Quinidine—KCNH2—Neuronal System—BRAF—bone cancer	6.58e-05	0.000845	CbGpPWpGaD
Quinidine—SCN3A—Axon guidance—MMP9—bone cancer	6.55e-05	0.000841	CbGpPWpGaD
Quinidine—CYP1A1—Biological oxidations—GSTP1—bone cancer	6.45e-05	0.000828	CbGpPWpGaD
Quinidine—CYP1A1—Metapathway biotransformation—GSTP1—bone cancer	6.36e-05	0.000816	CbGpPWpGaD
Quinidine—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	6.35e-05	0.000815	CbGpPWpGaD
Quinidine—SCN2A—Axon guidance—MMP9—bone cancer	6.29e-05	0.000808	CbGpPWpGaD
Quinidine—SCN3A—Developmental Biology—MMP2—bone cancer	6.22e-05	0.000798	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—NDUFA12—bone cancer	6.16e-05	0.00079	CbGpPWpGaD
Quinidine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	6.12e-05	0.000785	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	6.08e-05	0.000781	CbGpPWpGaD
Quinidine—SCN1A—Axon guidance—MMP9—bone cancer	6.07e-05	0.000779	CbGpPWpGaD
Quinidine—SCN2A—Developmental Biology—MMP2—bone cancer	5.98e-05	0.000767	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—NT5C3A—bone cancer	5.97e-05	0.000767	CbGpPWpGaD
Quinidine—CYP2C8—Biological oxidations—GSTP1—bone cancer	5.91e-05	0.000759	CbGpPWpGaD
Quinidine—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	5.83e-05	0.000748	CbGpPWpGaD
Quinidine—CHRM2—Regulation of Actin Cytoskeleton—BRAF—bone cancer	5.78e-05	0.000742	CbGpPWpGaD
Quinidine—SCN1A—Developmental Biology—MMP2—bone cancer	5.76e-05	0.00074	CbGpPWpGaD
Quinidine—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	5.72e-05	0.000735	CbGpPWpGaD
Quinidine—SCN5A—Axon guidance—MMP2—bone cancer	5.68e-05	0.000729	CbGpPWpGaD
Quinidine—CYP2D6—Biological oxidations—CYP3A4—bone cancer	5.67e-05	0.000728	CbGpPWpGaD
Quinidine—CYP2C9—Biological oxidations—CYP3A4—bone cancer	5.63e-05	0.000722	CbGpPWpGaD
Quinidine—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	5.6e-05	0.000718	CbGpPWpGaD
Quinidine—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	5.55e-05	0.000712	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	5.54e-05	0.000711	CbGpPWpGaD
Quinidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	5.52e-05	0.000708	CbGpPWpGaD
Quinidine—KCNH2—Neuronal System—MDM2—bone cancer	5.51e-05	0.000708	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—NT5C3A—bone cancer	5.48e-05	0.000704	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—NT5C3A—bone cancer	5.47e-05	0.000703	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	5.46e-05	0.000701	CbGpPWpGaD
Quinidine—SLC22A2—Transmission across Chemical Synapses—BRAF—bone cancer	5.36e-05	0.000688	CbGpPWpGaD
Quinidine—CHRM2—GPCR ligand binding—SMO—bone cancer	5.35e-05	0.000686	CbGpPWpGaD
Quinidine—SCN3A—Axon guidance—EGFR—bone cancer	5.29e-05	0.00068	CbGpPWpGaD
Quinidine—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	5.18e-05	0.000664	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—NT5C3A—bone cancer	5.1e-05	0.000655	CbGpPWpGaD
Quinidine—SCN2A—Axon guidance—EGFR—bone cancer	5.09e-05	0.000653	CbGpPWpGaD
Quinidine—SLC22A1—Transmission across Chemical Synapses—BRAF—bone cancer	5e-05	0.000641	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—RGS1—bone cancer	4.95e-05	0.000635	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—GRM4—bone cancer	4.95e-05	0.000635	CbGpPWpGaD
Quinidine—SCN1A—Axon guidance—EGFR—bone cancer	4.91e-05	0.00063	CbGpPWpGaD
Quinidine—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	4.9e-05	0.000629	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—NDUFA12—bone cancer	4.89e-05	0.000628	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—MET—bone cancer	4.86e-05	0.000623	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—CDK4—bone cancer	4.86e-05	0.000623	CbGpPWpGaD
Quinidine—CYP2D6—Biological oxidations—GSTP1—bone cancer	4.85e-05	0.000623	CbGpPWpGaD
Quinidine—CYP2C9—Biological oxidations—GSTP1—bone cancer	4.81e-05	0.000618	CbGpPWpGaD
Quinidine—CYP1A2—Biological oxidations—CYP3A4—bone cancer	4.81e-05	0.000617	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—NDUFA12—bone cancer	4.79e-05	0.000615	CbGpPWpGaD
Quinidine—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	4.79e-05	0.000614	CbGpPWpGaD
Quinidine—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	4.75e-05	0.000609	CbGpPWpGaD
Quinidine—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	4.74e-05	0.000609	CbGpPWpGaD
Quinidine—SCN3A—Developmental Biology—MMP9—bone cancer	4.68e-05	0.0006	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	4.63e-05	0.000594	CbGpPWpGaD
Quinidine—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	4.62e-05	0.000593	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—NDUFA12—bone cancer	4.52e-05	0.00058	CbGpPWpGaD
Quinidine—SCN2A—Developmental Biology—MMP9—bone cancer	4.49e-05	0.000577	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—RGS1—bone cancer	4.49e-05	0.000576	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—GRM4—bone cancer	4.49e-05	0.000576	CbGpPWpGaD
Quinidine—SLC22A2—Transmission across Chemical Synapses—MDM2—bone cancer	4.49e-05	0.000576	CbGpPWpGaD
Quinidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	4.34e-05	0.000557	CbGpPWpGaD
Quinidine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	4.34e-05	0.000557	CbGpPWpGaD
Quinidine—SCN1A—Developmental Biology—MMP9—bone cancer	4.33e-05	0.000556	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—GRM1—bone cancer	4.29e-05	0.00055	CbGpPWpGaD
Quinidine—SCN5A—Axon guidance—MMP9—bone cancer	4.27e-05	0.000548	CbGpPWpGaD
Quinidine—SLC22A1—Transmission across Chemical Synapses—MDM2—bone cancer	4.19e-05	0.000537	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—NDUFA12—bone cancer	4.14e-05	0.000532	CbGpPWpGaD
Quinidine—CYP1A2—Biological oxidations—GSTP1—bone cancer	4.11e-05	0.000528	CbGpPWpGaD
Quinidine—SLC22A2—Neuronal System—BRAF—bone cancer	4.11e-05	0.000527	CbGpPWpGaD
Quinidine—CHRM2—SIDS Susceptibility Pathways—JUN—bone cancer	4.06e-05	0.000521	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—NT5C3A—bone cancer	4.05e-05	0.00052	CbGpPWpGaD
Quinidine—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	4.05e-05	0.00052	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—MMP2—bone cancer	4.05e-05	0.00052	CbGpPWpGaD
Quinidine—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.99e-05	0.000512	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—NT5C3A—bone cancer	3.97e-05	0.00051	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—GRM1—bone cancer	3.89e-05	0.0005	CbGpPWpGaD
Quinidine—SLC22A1—Neuronal System—BRAF—bone cancer	3.83e-05	0.000491	CbGpPWpGaD
Quinidine—SCN3A—Developmental Biology—EGFR—bone cancer	3.78e-05	0.000485	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—NT5C3A—bone cancer	3.74e-05	0.000481	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—ENO2—bone cancer	3.67e-05	0.000471	CbGpPWpGaD
Quinidine—SCN2A—Developmental Biology—EGFR—bone cancer	3.63e-05	0.000466	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—NDUFA12—bone cancer	3.61e-05	0.000463	CbGpPWpGaD
Quinidine—SCN1A—Developmental Biology—EGFR—bone cancer	3.5e-05	0.000449	CbGpPWpGaD
Quinidine—SCN5A—Axon guidance—EGFR—bone cancer	3.45e-05	0.000443	CbGpPWpGaD
Quinidine—SLC22A2—Neuronal System—MDM2—bone cancer	3.44e-05	0.000442	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	3.43e-05	0.000441	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—NT5C3A—bone cancer	3.43e-05	0.000441	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—NDUFA12—bone cancer	3.4e-05	0.000437	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—DHFR—bone cancer	3.4e-05	0.000437	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—NDUFA12—bone cancer	3.37e-05	0.000433	CbGpPWpGaD
Quinidine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—bone cancer	3.31e-05	0.000425	CbGpPWpGaD
Quinidine—SLC22A1—Neuronal System—MDM2—bone cancer	3.21e-05	0.000412	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—GNA11—bone cancer	3.18e-05	0.000408	CbGpPWpGaD
Quinidine—CYP3A4—Biological oxidations—GSTP1—bone cancer	3.17e-05	0.000407	CbGpPWpGaD
Quinidine—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	3.13e-05	0.000402	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—ENO2—bone cancer	3.06e-05	0.000393	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—MMP9—bone cancer	3.05e-05	0.000391	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—NT5C3A—bone cancer	2.99e-05	0.000384	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—CYP3A4—bone cancer	2.88e-05	0.00037	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—NDUFA12—bone cancer	2.88e-05	0.00037	CbGpPWpGaD
Quinidine—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.87e-05	0.000368	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—DHFR—bone cancer	2.84e-05	0.000364	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—NT5C3A—bone cancer	2.82e-05	0.000362	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—NT5C3A—bone cancer	2.79e-05	0.000359	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—GNA11—bone cancer	2.76e-05	0.000355	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—SMO—bone cancer	2.74e-05	0.000352	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—GNA11—bone cancer	2.65e-05	0.000341	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—GRM4—bone cancer	2.65e-05	0.000341	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—RGS1—bone cancer	2.65e-05	0.000341	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—ENO2—bone cancer	2.62e-05	0.000336	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	2.55e-05	0.000327	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—GNA11—bone cancer	2.51e-05	0.000322	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—IL3—bone cancer	2.51e-05	0.000322	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—GSTP1—bone cancer	2.46e-05	0.000316	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—EGFR—bone cancer	2.46e-05	0.000316	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	2.45e-05	0.000315	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—DHFR—bone cancer	2.43e-05	0.000312	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—CYP3A4—bone cancer	2.41e-05	0.000309	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—ENO2—bone cancer	2.4e-05	0.000308	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—ENO2—bone cancer	2.4e-05	0.000308	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.39e-05	0.000307	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—NT5C3A—bone cancer	2.39e-05	0.000306	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—GRM1—bone cancer	2.3e-05	0.000295	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—IL3—bone cancer	2.27e-05	0.000292	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—GNA11—bone cancer	2.27e-05	0.000291	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—ENO2—bone cancer	2.24e-05	0.000287	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—DHFR—bone cancer	2.23e-05	0.000286	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—DHFR—bone cancer	2.22e-05	0.000286	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—NDUFA12—bone cancer	2.22e-05	0.000285	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	2.21e-05	0.000284	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—GNA11—bone cancer	2.08e-05	0.000267	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—GNA11—bone cancer	2.08e-05	0.000267	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—DHFR—bone cancer	2.07e-05	0.000266	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—GSTP1—bone cancer	2.06e-05	0.000264	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—CYP3A4—bone cancer	2.06e-05	0.000264	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.05e-05	0.000263	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—GNA11—bone cancer	1.94e-05	0.000249	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—CYP3A4—bone cancer	1.89e-05	0.000242	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—CYP3A4—bone cancer	1.88e-05	0.000242	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—NT5C3A—bone cancer	1.84e-05	0.000237	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—ENO2—bone cancer	1.78e-05	0.000228	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—GSTP1—bone cancer	1.76e-05	0.000226	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—CYP3A4—bone cancer	1.76e-05	0.000226	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—ENO2—bone cancer	1.74e-05	0.000223	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	1.74e-05	0.000223	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—DHFR—bone cancer	1.65e-05	0.000212	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—ENO2—bone cancer	1.64e-05	0.000211	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—SMO—bone cancer	1.62e-05	0.000208	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—GSTP1—bone cancer	1.61e-05	0.000207	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—DHFR—bone cancer	1.61e-05	0.000207	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—GSTP1—bone cancer	1.61e-05	0.000207	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—GNA11—bone cancer	1.54e-05	0.000198	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—DHFR—bone cancer	1.52e-05	0.000195	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—GNA11—bone cancer	1.51e-05	0.000194	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—ENO2—bone cancer	1.5e-05	0.000193	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—GSTP1—bone cancer	1.5e-05	0.000193	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—GNA11—bone cancer	1.48e-05	0.00019	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.46e-05	0.000187	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—GNA11—bone cancer	1.42e-05	0.000183	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—CYP3A4—bone cancer	1.4e-05	0.000179	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—DHFR—bone cancer	1.4e-05	0.000179	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—ATF1—bone cancer	1.38e-05	0.000177	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—CYP3A4—bone cancer	1.37e-05	0.000176	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—IL3—bone cancer	1.34e-05	0.000173	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—ENO2—bone cancer	1.31e-05	0.000168	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—GNA11—bone cancer	1.3e-05	0.000167	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—CYP3A4—bone cancer	1.29e-05	0.000165	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.28e-05	0.000165	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—PTGS2—bone cancer	1.28e-05	0.000164	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—ENO2—bone cancer	1.23e-05	0.000158	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—ENO2—bone cancer	1.22e-05	0.000157	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—DHFR—bone cancer	1.22e-05	0.000156	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—GSTP1—bone cancer	1.19e-05	0.000153	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—CYP3A4—bone cancer	1.18e-05	0.000152	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.18e-05	0.000151	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—GSTP1—bone cancer	1.17e-05	0.00015	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TGFBR2—bone cancer	1.15e-05	0.000148	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—DHFR—bone cancer	1.15e-05	0.000147	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—GNA11—bone cancer	1.14e-05	0.000146	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—DHFR—bone cancer	1.14e-05	0.000146	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—GSTP1—bone cancer	1.1e-05	0.000142	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—IGF1R—bone cancer	1.08e-05	0.000139	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—GNA11—bone cancer	1.07e-05	0.000137	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—PTGS2—bone cancer	1.07e-05	0.000137	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—GNA11—bone cancer	1.06e-05	0.000136	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—ENO2—bone cancer	1.05e-05	0.000134	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—CYP3A4—bone cancer	1.03e-05	0.000132	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—GSTP1—bone cancer	1.01e-05	0.00013	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—CYP3A4—bone cancer	9.7e-06	0.000125	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—DHFR—bone cancer	9.7e-06	0.000125	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—CYP3A4—bone cancer	9.62e-06	0.000123	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	9.57e-06	0.000123	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PTGS2—bone cancer	9.11e-06	0.000117	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—GNA11—bone cancer	9.07e-06	0.000116	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—GSTP1—bone cancer	8.81e-06	0.000113	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PTGS2—bone cancer	8.36e-06	0.000107	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PTGS2—bone cancer	8.35e-06	0.000107	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—GSTP1—bone cancer	8.3e-06	0.000107	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—GSTP1—bone cancer	8.23e-06	0.000106	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—CYP3A4—bone cancer	8.22e-06	0.000106	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	8.18e-06	0.000105	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—ENO2—bone cancer	8.07e-06	0.000104	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—KIT—bone cancer	7.84e-06	0.000101	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PTGS2—bone cancer	7.78e-06	9.99e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—DHFR—bone cancer	7.49e-06	9.61e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—BRAF—bone cancer	7.37e-06	9.46e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—EGFR—bone cancer	7.15e-06	9.17e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—GSTP1—bone cancer	7.03e-06	9.02e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—GNA11—bone cancer	7e-06	8.98e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PTGS2—bone cancer	6.19e-06	7.94e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MDM2—bone cancer	6.18e-06	7.93e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PTGS2—bone cancer	6.06e-06	7.78e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PTGS2—bone cancer	5.71e-06	7.33e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—GSTP1—bone cancer	5.43e-06	6.97e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—JUN—bone cancer	5.37e-06	6.89e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PTGS2—bone cancer	5.24e-06	6.72e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MMP9—bone cancer	5.22e-06	6.7e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PTGS2—bone cancer	4.56e-06	5.86e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PTGS2—bone cancer	4.3e-06	5.52e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PTGS2—bone cancer	4.26e-06	5.47e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—EGFR—bone cancer	4.22e-06	5.42e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PTGS2—bone cancer	3.64e-06	4.68e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TP53—bone cancer	3.54e-06	4.55e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PTGS2—bone cancer	2.81e-06	3.61e-05	CbGpPWpGaD
